10/28/2025 | Press release | Distributed by Public on 10/28/2025 04:01
|
Ticker:
|
ACJXX
|
American Cancer Society Support - Class I Shares
("Class I Shares")
|
ACTXX
|
American Cancer Society Support - Class T Shares
("Class T Shares")
|
|
ACOXX
|
American Cancer Society Support - Class N Shares
("Class N Shares")
|
|
Investment Objectives
|
|
Fees and Expenses of the Fund
|
|
ANNUAL FUND OPERATING EXPENSES
(expenses that you pay each year as a percentage of the value of your investment)
|
Class I
|
Class N
|
Class T
|
|||
|
Management Fees
|
0.20%
|
0.20%
|
0.20%
|
|||
|
Other Expenses(1)
|
0.20%
|
0.03%
|
0.29%
|
|||
|
Total Annual Fund Operating Expenses
|
0.40%
|
0.23%
|
0.49%
|
|||
|
Fee Waiver and/or Expense Reimbursement(2)
|
0.20%
|
0.03%
|
0.03%
|
|||
|
Total Annual Fund Operating Expenses After Fee Waiver and/or Expense Reimbursement(2)
|
0.20%
|
0.20%
|
0.46%
|
|
If Shares are redeemed:
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
Class I Shares
|
$ 20
|
$ 108
|
$ 204
|
$ 486
|
|
Class N Shares
|
$ 20
|
$ 71
|
$ 126
|
$ 290
|
|
Class T Shares
|
$ 47
|
$ 154
|
$ 271
|
$ 613
|
|
Principal investment strategies
|
|
Principal investment risks
|
|
Performance information
|
|
Annual Total Returns for Class T Shares (calendar year-end)
|
|
|
|
Best Quarter:
|
4th Quarter 2023
|
1.22%
|
Worst Quarter:
|
1st Quarter 2015
|
0.00%
|
|
Average Annual Total Returns (periods ended 12/31/24)
|
|||
|
1 Year
|
5 Years
|
10 Years
|
|
|
Class T Shares - Return Before Taxes
|
4.73%
|
2.11%
|
1.37%
|
|
Management
|
|
Purchase and sale of Fund shares
|
|
American Cancer Society Support - Class I Shares
|
|
|
Institutional investors investing through a cash portal
|
$250,000
|
|
Through an intermediary institution
|
|
|
• non-retirement accounts
|
$2,500
†
|
|
• certain tax-advantaged accounts or UTMA accounts
|
$500
†
|
|
American Cancer Society Support - Class N Shares
|
|
|
Retirement investors (investing through an adviser-assisted, employer-sponsored retirement plan)
|
None
|
|
Retail investors (investing through a financial intermediary omnibus account)
|
$2,500***
|
|
Institutional investors (investing directly with the Fund)
|
$1,000,000
|
|
American Cancer Society Support - Class T Shares
|
|
|
Through an intermediary institution
|
|
|
• non-retirement accounts
|
$2,500
†
|
|
• certain tax-advantaged accounts or UTMA accounts
|
$500
†
|
|
Tax information
|
|
Payments to broker-dealers and other financial intermediaries
|
|
Ticker:
|
ACDXX
|
American Cancer Society Support - Class D Shares
("Class D Shares")
|
|
Investment Objectives
|
|
Fees and Expenses of the Fund
|
|
ANNUAL FUND OPERATING EXPENSES
(expenses that you pay each year as a percentage of the value of your investment)
|
Class D
|
|
|
Management Fees
|
0.20%
|
|
|
Other Expenses(1)
|
0.21%
|
|
|
Total Annual Fund Operating Expenses
|
0.41%
|
|
|
Fee Waiver and/or Expense Reimbursement(2)
|
0.08%
|
|
|
Total Annual Fund Operating Expenses After Fee Waiver and/or Expense Reimbursement(2)
|
0.33%
|
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|
Class D Shares
|
$ 34
|
$ 124
|
$ 222
|
$ 510
|
|
Principal investment strategies
|
|
Principal investment risks
|
|
Performance information
|
|
Annual Total Returns for Class D Shares (calendar year-end)
|
|
|
|
Best Quarter:
|
4th Quarter 2023
|
1.22%
|
Worst Quarter:
|
1st Quarter 2015
|
0.00%
|
|
Average Annual Total Returns (periods ended 12/31/24)
|
|||
|
1 Year
|
5 Years
|
10 Years
|
|
|
Class D Shares - Return Before Taxes
|
4.77%
|
2.12%
|
1.39%
|
|
Management
|
|
Purchase and sale of Fund shares
|
|
Minimum Investment Requirements
|
|
|
To open a new regular Fund account
|
$2,500
|
|
To open a new regular Fund account with an automatic investment program of $50 per month
|
$100
|
|
To open a new UTMA account, Coverdell Education Savings Account, or a retirement Fund account
|
|
|
• without an automatic investment program
|
$1,000
|
|
• with an automatic investment program of $50 per month
|
$100
|
|
To add to any existing type of Fund account without an automatic investment program
|
$50
|
|
Tax information
|
|
Payments to broker-dealers and other financial intermediaries
|